From: Lippincott's NursingCenter.com
As nurses, we are responsible to advocate for the patients we care for and to act in their best interests without causing harm. While this may sound easy enough, conflicts often arise. For example, when our own beliefs and experiences interfere with the care we provide or when what we consider the "best interest" of the patient differs from the wishes of the patient or his family. End-of-life issues, advance directives, living wills, refusal of care, and informed consent are just a handful of "buzz words" that bring ethical considerations to mind.
We've compiled a Nursing Ethics Resource Page to help you, our colleagues, be ready to handle any ethical issues that you may face. Reading and re-reading some of these articles have even called to mind ethical dilemmas that I've dealt with in past experiences and allowed me to work through some of my own personal issues. Take some time to browse through these articles, share them with friends, and even share your thoughts, ideas, and experiences with us by leaving your comments. Ethics is a topic which is sure to generate discussion, and what better way is there for us to learn?
Thank you!
Lisa M. Bonsall, MSN, RN, CRNP,Clinical Editor, NursingCenter.com
Friday, July 10, 2009
Thursday, July 2, 2009
Public Health Advisory: FDA Issues Warning Regarding Levemir Insulin
The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market. Three lots or a total of 129,000 vials of this product were stolen in all. These stolen insulin vials may not have been stored and handled properly and may be dangerous for patients to use.
The FDA has received one report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots.
The agency is advising patients who use Levemir insulin to:
Check your personal supply of insulin to determine if you have Levemir insulin from one of the following lots: XZF0036, XZF0037, and XZF0038. Patients can locate the lot number on the side of the box of insulin and also on the side of the vial.
Do not use your Levemir insulin if it is from one of these lots. Replace it with a vial of Levemir insulin from another lot. If you must switch to another brand of insulin for any reason, first contact your healthcare provider as another insulin product may require adjustments in dosing.
Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.
Contact the Novo Nordisk Customer Care Center at 800.727.6500 for what to do with vials from these lots or if you have any other questions.
For more information:George Strait, Assistant Commissioner for Public Affairs U.S. Food and Drug Administration 301.796.4829
The FDA has received one report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots.
The agency is advising patients who use Levemir insulin to:
Check your personal supply of insulin to determine if you have Levemir insulin from one of the following lots: XZF0036, XZF0037, and XZF0038. Patients can locate the lot number on the side of the box of insulin and also on the side of the vial.
Do not use your Levemir insulin if it is from one of these lots. Replace it with a vial of Levemir insulin from another lot. If you must switch to another brand of insulin for any reason, first contact your healthcare provider as another insulin product may require adjustments in dosing.
Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.
Contact the Novo Nordisk Customer Care Center at 800.727.6500 for what to do with vials from these lots or if you have any other questions.
For more information:George Strait, Assistant Commissioner for Public Affairs U.S. Food and Drug Administration 301.796.4829
Subscribe to:
Posts (Atom)